AGP Picks
View all

The Boston Examiner
Provided by AGP

The Boston Examiner: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The Boston Examiner.

June 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30

July 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31

August 2026

Mo Tu We Th Fr Sa Su
1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30
31

Press releases published on June 9, 2026

Ernexa Therapeutics Highlights Ovarian Cancer Unmet Need, Hope for Patients and Potential Accessibility Advantages of ERNA-101 in Virtual Investor KOL Connect Segment Featuring Dr. Ira Winer
Jun. 9, 2026

Ernexa Therapeutics Highlights Ovarian Cancer Unmet Need, Hope for Patients and Potential Accessibility Advantages of ERNA-101 in Virtual Investor KOL Connect Segment Featuring Dr. Ira Winer

Indeterminate GlobeNewswire
Vericel to Present at the 2026 Truist Securities MedTech Conference on Tuesday, June 16, 2026
Jun. 9, 2026

Vericel to Present at the 2026 Truist Securities MedTech Conference on Tuesday, June 16, 2026

Indeterminate GlobeNewswire
Imviva Biotech Receives FDA Investigational New Drug Approval for CTA313, a Dual-Targeted CD19/BCMA Allogeneic CAR-T Cell Therapy for Autoimmune Diseases
Jun. 9, 2026

Imviva Biotech Receives FDA Investigational New Drug Approval for CTA313, a Dual-Targeted CD19/BCMA Allogeneic CAR-T Cell Therapy for Autoimmune Diseases

Indeterminate GlobeNewswire
Disc Medicine Provides Update from FDA Type A Meeting for Bitopertin in Erythropoietic Protoporphyria
Jun. 9, 2026

Disc Medicine Provides Update from FDA Type A Meeting for Bitopertin in Erythropoietic Protoporphyria

Indeterminate GlobeNewswire
Microbot Medical® Announces a Notable Health System as the First in Michigan to Adopt the LIBERTY® Endovascular Robotic System
Jun. 9, 2026

Microbot Medical® Announces a Notable Health System as the First in Michigan to Adopt the LIBERTY® Endovascular Robotic System

Indeterminate GlobeNewswire
New V2 Communications Research Reveals CEO Visibility Has Become a Business Imperative, Launches New Executive Visibility Services
Jun. 9, 2026

New V2 Communications Research Reveals CEO Visibility Has Become a Business Imperative, Launches New Executive Visibility Services

Indeterminate GlobeNewswire
Advanced Municipal Water Treatment Technologies Market to Reach $61.5 Billion by 2030, Driven by Stringent PFAS Regulations
Jun. 9, 2026

Advanced Municipal Water Treatment Technologies Market to Reach $61.5 Billion by 2030, Driven by Stringent PFAS Regulations

Indeterminate GlobeNewswire
MACOM and Elve to Demonstrate a V-Band Linearized TWTA for Satellite Communications and Defense Applications at IMS 2026
Jun. 9, 2026

MACOM and Elve to Demonstrate a V-Band Linearized TWTA for Satellite Communications and Defense Applications at IMS 2026

Indeterminate GlobeNewswire
Chiesi Global Rare Diseases Announces Health Canada Grants Priority Review for FILSUVEZ® (birch triterpenes) Topical Gel for the Treatment of Epidermolysis Bullosa
Jun. 9, 2026

Chiesi Global Rare Diseases Announces Health Canada Grants Priority Review for FILSUVEZ® (birch triterpenes) Topical Gel for the Treatment of Epidermolysis Bullosa

Indeterminate GlobeNewswire
Atavistik Bio Announces U.S. FDA Clearance of Investigational New Drug Application and Fast Track Designation for ATV-1601 for the Treatment of Hereditary Hemorrhagic Telangiectasia (HHT)
Jun. 9, 2026

Atavistik Bio Announces U.S. FDA Clearance of Investigational New Drug Application and Fast Track Designation for ATV-1601 for the Treatment of Hereditary Hemorrhagic Telangiectasia (HHT)

Indeterminate GlobeNewswire
Apollo Therapeutics Appoints Timothy P. Walbert as Chairman of the Board
Jun. 9, 2026

Apollo Therapeutics Appoints Timothy P. Walbert as Chairman of the Board

Indeterminate GlobeNewswire
BPGbio Appoints Renowned Neuroscientist Eric J. Nestler, M.D., Ph.D., as Chair of Scientific Advisory Board
Jun. 9, 2026

BPGbio Appoints Renowned Neuroscientist Eric J. Nestler, M.D., Ph.D., as Chair of Scientific Advisory Board

Indeterminate GlobeNewswire
Kymera Therapeutics Announces First Participant Dosed in Phase 1 Trial of Oral IRAK4 Degrader, KT-485, and Milestone Achievement Under Sanofi Collaboration
Jun. 9, 2026

Kymera Therapeutics Announces First Participant Dosed in Phase 1 Trial of Oral IRAK4 Degrader, KT-485, and Milestone Achievement Under Sanofi Collaboration

Indeterminate GlobeNewswire
Life Biosciences Announces First Patient Dosed in Phase 1 Trial of ER‑100 for Optic Neuropathies
Jun. 9, 2026

Life Biosciences Announces First Patient Dosed in Phase 1 Trial of ER‑100 for Optic Neuropathies

Indeterminate GlobeNewswire
TREOS Bio Presents New PEPI Technology Data at EACR 2026, Including Six-Year Cancer-Free Outcome in MSS Metastatic Colorectal Cancer (mCRC)
Jun. 9, 2026

TREOS Bio Presents New PEPI Technology Data at EACR 2026, Including Six-Year Cancer-Free Outcome in MSS Metastatic Colorectal Cancer (mCRC)

Indeterminate GlobeNewswire
Aware Expands Awareness Platform Capabilities with Key Partnerships to Deliver Smarter Identity Decisions
Jun. 9, 2026

Aware Expands Awareness Platform Capabilities with Key Partnerships to Deliver Smarter Identity Decisions

Indeterminate GlobeNewswire

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

The Boston Examiner

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.